Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas

Clinical trial NCT05751798 · RECRUITING

Trial details

NCT number: NCT05751798
Sponsor: OSE Immunotherapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Advanced Tumor Lymphoma NSCLC (Non-small Cell Lung Cancer)

Start date: 2022-12-20
Primary completion: 2029-12-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.